Dr Petrylak on Treatment With Enfortumab Vedotin/Pembrolizumab in Urothelial Carcinoma | OncLive
onclive.com
Dr Petrylak on Treatment With Enfortumab Vedotin/Pembrolizumab in Urothelial Carcinoma | OncLive
Daniel Petrylak, MD, discusses treatment with enfortumab vedotin plus pembrolizumab in patients with urothelial carcinoma in the community setting.
Apr 4, 2024
Related Products
Enfortumab Vedotin 30 Mg Injection
Enfortumab Vedotin Structure
Enfortumab Vedotin Skin Rash Images
#Enfortumab Vedotin Trials
ESMO 2023 Insights: "EV-302/KEYNOTE-A39 Study of Enfortumab Vedotin Pembro vs. Chemo in Previously Untreated la/mUC"
ESMO 2023 Insights: "EV-302/KEYNOTE-A39 Study of Enfortumab Vedotin Pembro vs. Chemo in Previously Untreated la/mUC"
vumedi.comOct 31, 2023
ASCO® 2024 Insights: "Impact of Exposure on Outcomes With Enfortumab Vedotin in Patients With Locally Advanced or Metastatic Urothelial Cancer"
ASCO® 2024 Insights: "Impact of Exposure on Outcomes With Enfortumab Vedotin in Patients With Locally Advanced or Metastatic Urothelial Cancer"
vumedi.comJun 6, 2024
Top videos
Dr Bedke on Advice for Using Enfortumab Vedotin/Pembrolizumab in Previously Untreated Advanced Urothelial Carcinoma | OncLive
Dr Bedke on Advice for Using Enfortumab Vedotin/Pembrolizumab in Previously Untreated Advanced Urothelial Carcinoma | OncLive
onclive.com
9 months ago
Erdafitinib versus enfortumab vedotin in previously treated urothelial carcinoma | Urology Times
Erdafitinib versus enfortumab vedotin in previously treated urothelial carcinoma | Urology Times
urologytimes.com
Apr 6, 2021
The role of enfortumab vedotin in urothelial cancer treatment
1:18
The role of enfortumab vedotin in urothelial cancer treatment
YouTubeVJOncology
386 viewsMay 31, 2024
Enfortumab Vedotin Results
Dr Lee on Safety Considerations for Enfortumab Vedotin in Metastatic Urothelial Cancer | OncLive
Dr Lee on Safety Considerations for Enfortumab Vedotin in Metastatic Urothelial Cancer | OncLive
onclive.com
Sep 27, 2024
Real-World EV-301 Data: Enfortumab Vedotin in Trial-Ineligible Patients - Kazutaka Nakamura
Real-World EV-301 Data: Enfortumab Vedotin in Trial-Ineligible Patients - Kazutaka Nakamura
urotoday.com
11 months ago
EV-302/KEYNOTE-A39: Open-Label, Randomized Phase 3 Study of Enfortumab Vedotin in Combination with Pembrolizumab vs Chemotherapy in Previously Untreated Locally Advanced or Metastatic Urothelial Carcinoma | OncLive
14:04
EV-302/KEYNOTE-A39: Open-Label, Randomized Phase 3 Study of Enfortumab Vedotin in Combination with Pembrolizumab vs Chemotherapy in Previously Untreated Locally Advanced or Metastatic Urothelial Carcinoma | OncLive
onclive.com
Oct 31, 2023
Dr Bedke on Advice for Using Enfortumab Vedotin/Pembrolizumab in Previously Untreated Advanced Urothelial Carcinoma | OncLive
Dr Bedke on Advice for Using Enfortumab Vedotin/Pembrolizum…
9 months ago
onclive.com
Erdafitinib versus enfortumab vedotin in previously treated urothelial carcinoma | Urology Times
Erdafitinib versus enfortumab vedotin in previously treated uroth…
Apr 6, 2021
urologytimes.com
The role of enfortumab vedotin in urothelial cancer treatment
1:18
The role of enfortumab vedotin in urothelial cancer treatment
386 viewsMay 31, 2024
YouTubeVJOncology
What is the optimal duration of treatment of enfortumab vedotin in urothelial carcinoma?
1:35
What is the optimal duration of treatment of enfortumab vedotin i…
624 viewsOct 15, 2024
YouTubeVJOncology
Dr. Glaucomflecken Explains: Enfortumab Vedotin and Pembrolizumab in Bladder Cancer (KEYNOTE-905) | Wesley Verla
Dr. Glaucomflecken Explains: Enfortumab Vedotin and Pembroli…
1 week ago
linkedin.com
Enfortumab vedotin for the treatment of advanced urothelial cancer
1:58
Enfortumab vedotin for the treatment of advanced urothelial c…
203 viewsDec 11, 2023
YouTubeVJOncology
Dr Lee on Safety Considerations for Enfortumab Vedotin in Metastatic Urothelial Cancer | OncLive
Dr Lee on Safety Considerations for Enfortumab Vedotin in Metastatic …
Sep 27, 2024
onclive.com
2:55
Comment: Enfortumab vedotin is an effective therapy and important de…
86 viewsJun 20, 2019
YouTubeecancer
ASCO® 2024 Insights: "Impact of Exposure on Outcomes With Enfo…
Jun 6, 2024
vumedi.com
4:06
Targeting agent enfortumab vedotin a novel treatment for patients wit…
116 viewsJun 20, 2019
YouTubeecancer
Treatment Optimization and Management of AEs with Enfortu…
9 months ago
springer.com
0:59
Treating enfortumab vedotin related AEs in urothelial carcinoma
123 viewsMar 10, 2025
YouTubeVJOncology
1:24
Enfortumab mode of action
1.2K viewsJan 28, 2023
YouTubeAsif Biotech
1:23
Padcev (enfortumab vedotin): Uses, How It Works, and Common Side …
947 views8 months ago
YouTubeDrugs.com
1:31
Dr Lee on the Efficacy of Enfortumab Vedotin Plus Pembrol…
551 viewsJan 16, 2025
YouTubeOncLive
3:50
Padcev (enfortumab vedotin): new medicine for treatment of urinary …
2.2K viewsJan 19, 2020
YouTubeAstroByte
3:46
Dr. Rana McKay on the Enfortumab Vedotin Combo Receiving an FDA …
174 viewsApr 10, 2023
YouTubeGU Oncology Now
2:31
Enfortumab vedotin improves efficacy outcomes in locally advan…
123 viewsJun 26, 2024
YouTubeecancer
2:39
Enfortumab Vedotin Approved by FDA for Patients With Refractory …
388 viewsJan 10, 2020
YouTubeGrand Rounds in Urology
0:34
Enfortumab vedotin for urothelial cancer in the real-world setting
254 viewsJan 29, 2024
YouTubeVJOncology
6:09
Enfortumab Vedotin for Previously-Treated Advanced Urothelial Carci…
1.2K viewsApr 22, 2021
YouTubeGrand Rounds in Urology
14:04
EV-302/KEYNOTE-A39: Open-Label, Randomized Phase 3 Study of Enf…
Oct 31, 2023
onclive.com
Real-World EV-301 Data: Enfortumab Vedotin in Trial-Ineligi…
11 months ago
urotoday.com
10:57
🎙️Episode 7: EV-302 Trial on Enfortumab Vedotin + Pembrolizu…
133 viewsMay 17, 2025
YouTubeOncoTrial Insights with Dr.Pidugu
2:23
Enfortumab Vedotin–Pembrolizumab in Advan…
5K viewsMar 7, 2024
YouTubeNEJM Group
ESMO 2023 Insights: "EV-302/KEYNOTE-A39 Study of Enfort…
Oct 31, 2023
vumedi.com
2:30
The future of antibody-drug conjugates in urothelial cancer
135 viewsFeb 9, 2024
YouTubeVJOncology
2:12
Dr McGregor on Sacituzumab Govitecan Plus Enfortumab Vedoti…
Feb 5, 2024
onclive.com
1:21
Optimizing Enfortumab Vedotin & Pembrolizumab for Urothelial Can…
137 views10 months ago
YouTubeOncotarget
See more videos
Static thumbnail place holder